ST Pharm Co., Ltd.Seoul, Seoul-t'ukpyolsi, Republic of Korea
Disclosure information not submitted.
172 - The First Proof-of-Concept Clinical Trial of an HIV-1 Allosteric Integrase Inhibitor, Pirmitegravir (STP0404)
Monday, October 20, 20251:57 PM - 2:09 PM US ET